CD24 and ovarian cancer: Patients with triple-negative breast cancer (TNBC) and ovarian cancer have a fraction of tumor-associated macrophages (TAM) in the tumor microenvironment (TME) that highly express Siglec-10, the main ligand for CD24, which is widely expressed by B cells, activated T cells, and monocytes [22].